Patent dispute over erythropoietin terminated

Darae patent office said that the domestic production of erythropoietin, an biotechnology based antianemic drug, may be further activated, as CJ, a local pharmaceutical firm, won the patent dispute touched off by the U.S.-based Genetics Institute (GI) in a trial to confirm the scope of patent right on the manufacture of erythropoietin on July 24, 2003.

As for the process of manufacturing ery...